Continued Poor Survival in Metastatic Uveal Melanoma Implications for Molecular Prognostication, Surveillance Imaging, Adjuvant Therapy, and Clinical Trials

JAMA OPHTHALMOLOGY

AMER MEDICAL ASSOC

1. Bristol-Myers Squibb
2. Incyte Corp.
3. Alcon Research Institute
4. Knights Templar Eye Foundation
5. National Eye Institute
6. Spectrum Pharmaceuticals
7. Research to Prevent Blindness